Financing, Equity Capital Markets

BridgeBio Pharma, Inc.

06/19
|
$400.8 Million
Piper Sandler served as bookrunner for BridgeBio Pharma, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma